About BioAmp Diagnostics
BioAmp Diagnostics is a company based in Berkeley (United States) founded in 2017 by Nicole Tarlton. BioAmp Diagnostics offers products and services including DETECT Technology. BioAmp Diagnostics operates in a competitive market with competitors including Lodestone Biomedical, Araceli Biosciences, BioImage, HAWK Biosystems and Genosaber, among others.
- Headquarter Berkeley, United States
- Founders Nicole Tarlton
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$243.81 K (USD), Grant
Apr 02, 2024
-
Investors
Illumina
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAmp Diagnostics
BioAmp Diagnostics offers a comprehensive portfolio of products and services, including DETECT Technology.
Rapid chemistry-based system for quick infection detection and antibiotic guidance.
People of BioAmp Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of BioAmp Diagnostics
Investors in BioAmp Diagnostics
BioAmp Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, National Science Foundation and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
Startup accelerator program is backed by University of California.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for BioAmp Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioAmp Diagnostics
Investment portfolio details for BioAmp Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioAmp Diagnostics
Detailed financials for BioAmp Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioamp Diagnostics Comparisons
Peer comparison for BioAmp Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioAmp Diagnostics
BioAmp Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, Araceli Biosciences, BioImage, HAWK Biosystems and Genosaber, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| Locked | Locked | Locked |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
|
| Locked | Locked | Locked |
Bioassays are developed for biopharmaceutical firms and research organizations.
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| Locked | Locked | Locked |
Diagnostic tools for detecting circulating tumor cells are developed.
|
Detailed competitors of BioAmp Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioamp Diagnostics
Complete news archive for BioAmp Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioAmp Diagnostics
BioAmp Diagnostics was founded in 2017.
BioAmp Diagnostics is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.
BioAmp Diagnostics's top competitors include Araceli Biosciences, Lodestone Biomedical and BioImage.
BioAmp Diagnostics offers DETECT Technology.
BioAmp Diagnostics has 4 investors. Key investors include Illumina, National Science Foundation, America’s Seed Fund, and CITRIS Foundry.